MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202527095984 A) filed by Bluejay Therapeutics, Inc. on October 06, 2025, for Anti-Hbsag Antibody For Treatment Of Chronic Hepatitis D.
Inventor includes Javanbakht, Hassan.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention relates to anti-HBsAg antibodies, antibody fragments, and their uses for the prevention and treatment of hepatitis D virus infection and associated diseases. A method of neutralizing a hepatitis D virus infection comprising administering via injection or infusion to a patient in need an effective amount of the antibody, wherein said antibody or antigen binding fragment, is provided.
Disclaimer: Curated by HT Syndication.
